Monday had a little bit of everything: geopolitical headlines, a regulatory green light, a surprise buyout, and another burst of AI infrastructure enthusiasm.
Biotech was far less forgiving, with several names getting knocked back despite important developments on the calendar.
Keep reading for the movers that turned those competing stories into some of the day’s sharpest stock moves in markets.
Backdoor Anthropic (Sponsored)
Marc Chaikin, the 60-Year Wall Street legend who called Nvidia before it soared 45,000%, says a dramatic shift in AI is unfolding right now behind locked doors in Silicon Valley.
As AI wakes up and gains free will, Marc has prepared a FREE investment playbook specifically for this moment in history - including a backdoor, pre-IPO way into Anthropic before they go public.
All the details are FREE right here...
*This ad is sent on behalf of Chaikin Analytics, 201 King Of Prussia Rd., Suite 650, Radnor, PA 19087. If you would like to optout from receiving offers from Chaikin Analytics please click here.
Elite Trade Club Insider
A New CEO Bought $1 Million While A Biotech Founder Sold Nearly $11 Million
You’re looking at one regional banking giant entering a new leadership era and one biotech company spending heavily to build its post-COVID oncology future. Elite Trade Club Insider readers are seeing how the people closest to those stories are positioning: a newly appointed CEO put $1.02 million of fresh cash into his stock, while a biotech founder sold nearly $11 million through a plan established months ago.
You’re reading the free version. Here’s what we held back.
Every day, insiders and institutions move millions before the market catches on. We surface the data behind those moves before the rest of the market sees it.
A subscription gets you:
The insider buys, options bets, and dark pool moves the free edition can't show you. Unlocked every weekday.
A Sunday Deep Dive that tells you where to look before Monday's bell rings.
The Friday Smart Money Brief: who bought, who sold, where the big options bets landed, and where institutions are hiding volume. Three data layers. One email.
A Monthly Insider Scorecard so you always know whether smart money is buying or selling the market.
Every past Insider edition, unlocked, on elitetrade.club. Go back and see what you missed.
$25/mo or $250/yr. 30-day money back guarantee. Cancel anytime. Founding member pricing: lock in $25/mo before we raise it.
Markets
Falling oil prices helped loosen financial conditions Monday, while optimism around Washington-Beijing talks gave technology and AI shares another lift.
Bitcoin climbed back above $86,000, adding fuel to crypto-linked risk appetite, while lower Treasury yields helped keep the broader tone constructive. Meta’s AI-agent rollout also gave the technology trade another jolt.
Against that backdrop, Greenland-linked rare-earth names surged after a new U.S.-Denmark-Greenland security agreement, while Priority Technology jumped on its take-private deal.
The session had plenty of moving parts, but the biggest stock stories came from specific catalysts rather than one broad market narrative. Meanwhile, chipmakers and other AI-linked names continued to pull money toward growth stocks.
DJIA: +0.71%
S&P 500: +1.49%
Nasdaq: +2.26%
Russell 2000: +0.59%
Market-Moving News
Media & Streaming
AT&T's wireless turnaround is winning over skeptics as BNP Paribas upgraded the carrier to Outperform and raised its price target to $30 from $26; the firm now sees postpaid phone ARPU growing 1.1% annually, up from a prior 0.2% estimate, adding billions in incremental revenue and free cash flow over time.
FanDuel's parent is losing Wall Street's patience after Rothschild & Co Redburn downgraded Flutter Entertainment to Neutral and slashed its price target to $119 from $169; the firm pointed to four consecutive guidance cuts in 2026, including a 22% reduction to FanDuel's EBITDA midpoint.
Technology & Hardware
Intel is finding a new growth lane in AI packaging after striking a Micro LED advanced-packaging partnership with AU Optronics; the deal targets co-packaged optics and high-density computing integration for next-generation AI chips, sending Intel shares up more than 9% in early trading.
AMD's AI chips are about to get pricier after a supply-chain report said the company plans to raise prices roughly 10% on AI accelerators, consumer GPUs and motherboard chipsets starting in the fourth quarter; AMD hasn't confirmed the report, but shares jumped as much as 9% on hopes of stronger pricing power.
Financial Services & Insurance
Coinbase is making its case as crypto's "everything exchange" after Wall Street piled on price-target hikes, with Goldman Sachs raising its target to $219, Needham to $200, and Morgan Stanley initiating coverage at $250.
Strategy is riding bitcoin's best run since January as the stock climbed 6% to $163.68 while bitcoin surged to $85,131, its highest level since the start of the year; bitcoin-mining peers MARA and Riot Platforms also gained, though no company-specific news accompanied the sector-wide bid.
Gold Outlook Rising (Sponsored)
Gold is trading above $4,300 an ounce, and J.P. Morgan says prices could climb toward $6,000 by year-end 2026 and potentially $6,300 by the end of 2027.
That outlook is getting the attention of retirement investors looking to diversify beyond stocks and bonds.
A free guide explains how eligible retirement savings may be used to add physical gold without triggering an immediate taxable distribution when structured correctly.
See How to Position Your Retirement Savings for Higher Gold
Healthcare & Pharmaceuticals
Novo Nordisk's decade-ahead roadmap isn't reassuring investors after the drugmaker unveiled plans for more than five new "multi-blockbuster" obesity drugs by 2030 and $23 billion in pipeline sales by 2035; shares still fell 6% as investors weighed looming semaglutide patent expiration and Eli Lilly's widening market-share lead.
Insmed is closing in on an expanded lung-disease label after the FDA granted Priority Review to its supplemental application for ARIKAYCE in MAC lung disease; the filing rests on positive Phase 3b data from the 425-patient ENCORE study, with a PDUFA target action date set for January 28, 2027.
Policy & Regulation
Wall Street is cheering an apparent trade thaw before Thursday's summit after Treasury Secretary Scott Bessent called weekend talks with China "a very successful engagement" ahead of Xi Jinping's state visit; both sides reportedly discussed reciprocal tariff cuts on $30 billion of goods each, sending futures higher and oil down more than 3%.
California's attorney general is clearing a path for the year's biggest media merger after advancing settlement talks with Paramount Skydance over its $110 billion bid for Warner Bros. Discovery; the emerging terms reportedly include a $1.5 billion California production commitment and a governance board to preserve editorial independence, sending both stocks surging in premarket trading.
Top Winners and Losers
Greenland Mines [GRML] $9.42 (+230.53%)
Greenland Mines turned into the day's biggest story after this week's US Greenland Denmark security pact put critical minerals squarely in the spotlight, and the company's recently completed Sarfartoq rare earth acquisition suddenly looked perfectly timed.
A prior reverse split left the float razor thin, which only added rocket fuel to the move. Geopolitics meets microcap math.
Twin Vee PowerCats [VEEE] $17.24 (+104.02%)
Twin Vee PowerCats is merging with USFM Corporation, a company chasing strategic mineral assets in Greenland, while spinning its actual boat business into a separate trust for existing shareholders.
Investors clearly preferred the mineral story to the marine one today. Funny what a pivot to rare earths can do for a boat maker's stock price.
Critical Metals Corp [CRML] $9.33 (+38.63%)
Critical Metals rode the same Greenland security pact wave as its mining peers today, with fresh talk of a Romanian refinery adding another leg to the rare earth ambitions story.
No single new filing explains the entire pop, but the sector-wide enthusiasm for anything touching critical minerals did plenty of the heavy lifting.
SMX (Security Matters) [SMX] $10.98 (-35.45%)
SMX has been riding a molecular marking story tied to recycled plastics and rising oil prices, and today's drop looks like a hard reset after that run got ahead of itself.
With oil actually falling today rather than rising, the trade behind last week's enthusiasm lost its main talking point. Momentum names cut both ways.
Cue Biopharma [CUE] $23.70 (-28.27%)
Cue Biopharma is giving back a chunk of Friday's monster rally, which came after the company posted positive Phase 2 results showing most patients went hive-free in a chronic hives trial.
Great data, but a stock that already priced in the good news had nowhere to go but down once the initial excitement faded. Sell the news, biotech style.
Antelope Enterprise [AEHL] $6.92 (-17.72%)
Antelope Enterprise keeps deflating after last week's convertible note-fueled sprint from single digits into double digits, with today's drop just the latest leg of that comedown.
There is no new headline attached, just a thinly traded name settling back toward earth after an emotional few sessions. What goes up this fast tends to come down just as quickly.
Marketwide circuit breakers halt trading at a 7% drop. Should the market ever be halted?
Elon’s $126T Move (Sponsored)
I just got back from a $7,500 tech conference in L.A.
Nvidia. Microsoft. SpaceX. Even President Trump joined.
He hinted at a business move that could create $126 trillion in wealth—and send one $15 stock soaring.
See the Full Story
This ad is sent on behalf of InvestorPlace Media at 1125 N. Charles Street, Baltimore, Maryland 21201. If you're not interested in this opportunity, please click here.
Everything Else
Seven stocks are quietly doing what the Mag 7 did early on and a free report names all of them before the rotation becomes obvious.
Oura filed for a Nasdaq IPO targeting up to $2.2 billion raised and a valuation near $14 billion for the smart-ring maker.
HP warned that global PC volumes will shrink by mid-single digits in 2027, sending shares down 2%.
Marvell jumped 6% after unveiling a 2-nanometer optical interconnect demo ahead of a European tech conference, prompting Morgan Stanley to raise its price target.
Meta spiked 7% after Wells Fargo lifted its price target to $796, pointing to growing traction for its "Muse" AI agent ahead of this week's Connect event.
You Read This Far. Here's Where the Real Work Lives.
We run three live portfolios on Autopilot, and everything about them is public: every position, every allocation, every trade, visible the moment it happens.
We keep our own money in each one, because analysis you won't fund yourself is just content.
THE UNBREAKABLE STACK
Our growth book: durable software and cybersecurity names built to compound quietly for years.
THE HORMUZ PREMIUM
Our energy thesis: built for how that sector actually pays, over quarters, not headlines.
THE ELON INDEX
Our conviction bet on the Musk universe: Tesla, and the companies orbiting his ventures, energy, AI, infrastructure. High-beta by design, for investors who want direct exposure to the trade rather than watching it from the sidelines.
And here's the part that makes it effortless: Autopilot does the trading for you. Connect the brokerage you already use (Robinhood, Schwab, Fidelity, and more) and every move we make gets mirrored in your own account automatically.
Your money never leaves your brokerage. It stays in your account, under your control, and you can override any trade or disconnect anytime. Autopilot even rebalances automatically when allocations drift, and you get a notification every time something happens.
No watching tickers. No timing entries. No fat-finger mistakes at market open. You pick the portfolio, we do the work, your account follows along.
Pick the one that fits your risk level, or run all three:
Live portfolios, real positions, our own capital at stake. Your funds stay in your own brokerage account. Past performance doesn't guarantee future results.
That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!
Thanks for reading. I'll see you at the next open!
Best Regards,
— Adam G.
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
